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Several of the animal lentiviruses, including visna virus of sheep and caprine
arthritis-encephalitis virus ofgoats, are known to infect cells ofthe monocyte/mac-
rophage lineage. Studies with visna, the prototype lentivirus, have demonstrated
that monocyte/macrophages play a critical role in pathogenesis, since these cells act
as a reservoir for virus and disseminate infection to target organs such as the lung
and centralnervous system (1-3). A similarrolehasbeen proposed formonocyte/mac-
rophages in HIV infection ofhumans (4, 5), since these cells have been shown to
be infected in HIVpositive subjects (6-11), and can be experimentally infected in
vitro (12-18).
Seminal studiesofvisna-maedi ofsheep demonstrated thatdifferent strains ofvisna
virusexhibited marked differencesin theircellular tropism, some isolatesbeingmono-
cytetropic whileothers were fibroblast tropic (1, 4, 19, 20). Furthermore, visnavirus
strains that showed different tropism in cell culture had different patterns ofviru-
lence when injected into sheep (20). Likewise, it appears that HIV-1 isolates vary
in their ability toreplicate in monocyte/macrophages, and this may correlatein part
with the site and method ofisolation (6, 16, 21-24). It is plausible that these differ-
ences may be important in the persistence, dissemination, pathogenesis, or trans-
mission of HIV infection (25).
This study was designed to address several aspects ofHIV-1 infection ofmono-
cyte/macrophages. (a)Wewished to confirm the existence ofmonocyte-tropic strains
and todeterminetheir relativeabilityto replicatein primarycultures ofmonocyte/mac-
rophages and oflymphocytes. (b) Since theuseofprimarycellsisfraughtwithdifficul-
ties, we wanted to determine whether promonocyte cell lines or lymphoid cell lines
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could be used as surrogates for primary cultures in studies of viral tropism. (c) In
addition, we addressed several related issues. Does HIV-1 infection of monocyte-
derived macrophages (MDM)' involve the majority of the cell population or is in-
fection associated with a subpopulation ofMDM or with a few residual contaminating
CD4+ lymphocytes? Does HIV-1 produce any cytopathic effect on MDM?
The results indicate that the host range of HIV is a complex phenomenon best
characterized by using a matrix of several different cell types, and that HIV infec-
tion of monocyte/macrophages differs markedly from infection of lymphocytes
justifying extensive independent study.
Materials and Methods
Cell Isolation and Culture ofMDM.
￿
Monocyte-enriched populations were prepared from
PBMC of HIVseronegative volunteers as described (26) and cultured in vitro as MDM.
PBMC obtained by Ficoll-Hypaque separation of whole bloodwere suspended at 2-4 x 106
cells/ml in DME (Gibco Laboratories, Grand Island, NY) and 20 ml was placed in 75-cm2
tissue culture flasks (Corning Glass Works, Corning, NY) previously coated with 2% gelatin.
After incubation for 1 h at 37 °C, nonadherent cells were removed, and the adherent cells
were washed four times with serum-free DME and once with 10 ml of a 1 :1 mixture of 10
mM EDTA in PBS and DME with 20% horse serum (Gibco Laboratories). Adherent cells
were detached by incubation for 15 min with 10 ml of the EI7TA-horse serum mixture, washed
in DME, and suspended at 5 x 105 cells/ml in DME with 10% FCS (HyClone Laborato-
ries, Logan, UT), 10% horse serum (Gibco Laboratories), glutamine (600 kg/ml), penicillin
(100 U/ml), streptomycin (100,ug/ml), granulocyte-macrophage CSF (GM-CSF, 40 U/ml;
Amgen, Thousand Oaks,CA [27]), and macrophage CSF (M-CSF, 100 U/ml; kindly provided
by Genetics Institute, Cambridge, MA [28]). Suspended cells were seeded at 2-5 x 105
cells/well in 24- or 48-well plastic tissue culture plates (Flow Laboratories, McLean, VA; or
Gibco Laboratories) and maintained at 37°C in 5% C02. Once weekly, cultures were
washed with PBS to remove nonadherent cells, and refed with media containing CSFs.
Preliminary studies showed that in combination, M-CSF and GM-CSF improved the via-
bility of uninfected MDM cultures (27, 29) from _50% at 4 wk and _25% at 8 wk to _80%
and _60%, respectively (data not shown). Therefore, CSFs were added at the initiation of
macrophage cultures and replaced each time medium was changed. Selected batches of fresh
medium were tested periodically and shown to be free of endotoxin by the limulus amoebo-
cyte lysate assay (QCL-1000; Whittaker M. A. Bioproducts, Walkersville, MD).
After initial purification, cells were 390% monocytes as determined by surface markers,
latex phagocytosis, and nonspecific esterase (Fig. 1, Table I), and after 7 d in culture were
397% monocyte/macrophage cells by the same criteria (Table I).
PBL.
￿
Lymphocyte-enriched cultures were prepared from PBMC by adherence deple-
tion of monocytes. PBMC were suspended at 106 cells/ml in RPMI with 10% FCS (Gibco
Laboratories), penicillin(100 U/ml), streptomycin (100 Rg/ml), glutamine (300 ug/ml), nones-
sential amino acids (1%; Gibco Laboratories), and PHA-L (5 Wg/ml; Sigma Chemical Co.,
St. Louis, MO). After 24 h the nonadherent cells were transferred to a new flask and 2-3 d
later the nonadherent cells were resuspended at 106 cells/ml in wells in medium (without
PHA) supplemented with rIL-2 (600 U/ml; DuPont Co., Wilmington, DE). Lymphocytes
were maintained with IL-2 and split 1 :2-1 :4 every 5 d. At 4 d of culture, these cells were
_75% T lymphocytes and 15% B lymphocytes by surface markers, and <2% reacted with
surface markers for monocyte/macrophages (Table I).
U937 and SUP-TI Cells.
￿
U937 promonocytic (30) and SUPTI T lymphocyte (31) cell
lineswere maintained at _106 cells/ml in RPMI with 10% FCS, penicillin(100 U/ml), strep-
tomycin (100 lzg/ml), and glutamine (300 lAg/ml); cells were split 1 :4 every 5 d.
I Abbreviations used in thispaper GM-CSF, granulocyte-macrophage CSF; M-CSF, macrophageCSF;
MDM, monocyte-derived macrophages.COLLMAN ET AL.
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Analysis of Cell Populations.
￿
Immunofluorescent detection of surface markers was carried
out with mAbs OKMI (anti-CD11b/CR3; OrthoDiagnostic SystemsInc., Westwood, MA),
OKT3 (anti-CD3, Ortho Diagnostic Systems, Inc.), OKT4 (anti-CD4; Ortho Diagnostic
Systems Inc.), OKT11 (anti-CD2; Ortho Diagnostic SystemsInc.), Leu-M3 (anti-CD14; Bec-
ton Dickinson&Co., Mountain View, CA), HD37 (anti-CD19; Boehringer Mannheim Bio-
chemicals, Indianapolis, IN), 12 (anti-la; Coulter Electronics, Inc., Hialeah, FL), B73.1
(anti-FcR/NK; provided by G. Trinchieri, The Wistar Institute, Philadelphia, PA [32]), and
isotype-matchedcontrol antibodies. Cell lines, lymphocytes, and freshly isolated monocytes
in suspension were incubated for 30 min at 4°C with mAb at 1:10-1:20 dilution, washed
twicewith PBSwith 21 7o FCS, incubated for30 min at 4°C with fluorescein-conjugated goat
F(aV)2 anti-mouse IgG (Organon Teknika Corp., Durham, NC) diluted 1:60, washed and
analyzed by flow cytometry (Epics; Coulter Electronics, Inc.), or mounted on glass slides
and assessed by fluorescent microscopy. Fordetectionofsurfacemarkerson adherent MDM,
cells were cultured on polylysine-coated glass cover slips, fixed with methanol for 30 min at
room temperature, washed twice with PBS, andoverlaid with 20% nonimmune rabbit serum
and 5% nonimmune goat serum (Organon TeknikaCorp.) for 20 min at room temperature
to blocknonspecific binding. Cellswere then incubatedfor45 minat room temperature with
mAb diluted 1:10 in PBS containing 5% goat and 20% rabbit serum, washed twice with
PBS, and incubated for 30 minwith fluorescein-conjugated goat F(ab)2 anti-mouse IgG (Or-
ganon TeknikaCorp.) diluted 1:60 in PBScontaining 50% FCS, 1017o goat serum, 10% rabbit
serum, and 0.5% Evans blue as acounterstain to minimize autofluorescence. Coverslips were
mounted on glass slides and examined by fluorescent microscopy.
Monocyte/macrophage cultures were examined by modified Wright-Giemsa stain (Dif-
Quik; American Scientific Products, McGaw Pk, IL). Nonspecific esterase was demonstrated
cytochemically (diagnostic kit 181B; Sigma Chemical Co. [33]). Latex phagocytosis was de-
tected by incubating cellsfor 1 hwith 1.1-Amlatexparticles (Dow Chemical Co., Indianapolis,
IN); cultures were scored microscopically for intracellular particles (34). Fc receptors were
detected by rosette formation with IgG-coated sheep erythrocytes (35). Sheep erythrocytes
were incubatedwith rabbit anti-sheep erythrocyte IgG(Organon TeknikaCorp.) for30 min
at 37°C, washed three times with PBS, and incubated with monocyte/macrophages for 1 h
at 37°C, which were then washed, fixed, and stained with Wright-Giemsa stain. Cells with
three or more adherent erythrocytes were scored positive. Quantification was based on a
minimum of 300 cells visualized microscopicallyor 5,000 cells analyzed by flow cytometry.
Viruses.
￿
HIV-I strains HIVIIIB (36) and HIVDV (37) were isolated from PBMC, and
HIVSF162 (24) was isolated from cerebrospinal fluid. Virus stocks were grown in SUP-T1
cells or PHA/IL-2-stimulatedlymphocytes, and clarified supernatant was frozen at -80°C.
Stocks were titered by p24antigen contentandby TCID50 titrationon PBL or SUP-T1 cells.
Theinfectious titer per 100ng p24 antigenwas: IIIB, 5.6 x 104TCID50; DV, 105 TCID50;
and SF162, 5.3 x 103 TCID50.
HIV-1 Infection.
￿
Monocyte/macrophages were infected as MDM after 7-14 d in culture.
Cells were washed four timeswith PBS, and the viral inoculum was added. After incubation
for 2 h at 37°C, cells were washed four times with PBS to remove unadsorbed virus, and
fresh medium was added. Lymphocytes were cultured for 4 d before infection. Virus was
added to 106 cells in 1 ml for 2 h at 37°C, washed four times with PBS, and cells were
resuspended at the same density in medium containing IL-2. U937 and SUPTI cells were
infected by the same protocol. In each experiment the final wash was tested for viral p24
antigen and shown to be free of residual inoculum.
Virus Detection.
￿
All samples were stored at -80°C until assayed. p24 antigen was deter-
mined on tissue culture supernatant or on cell pellets lysed with 1% Triton X-100 (and
resuspended to the original culture volume) by ELISA (Coulter Electronics, Inc.). Tissue
culture infectious dose 50% endpoint (TCID50) wasdetermined by inoculating replicatemi-
crotiter wells of SUP-T1 cells (104 cells/well) or PHA-stimulated lymphocytes (5 x 104
cells/well, with IL-2) with serial dilutions of cell-free supernatant. Lymphocyte wells were
split 1:5 once weekly and fedwith fresh medium containing IL-2. After3 wk, each well was
scored for the presence of syncytia (SUP-TI cells) or for p24 antigen production (lympho-
cytes) by ELISA(Chiron Corp., Emeryville, CA). MDMcultured on polylysine-coated glass1152 HUMAN IMMUNODEFICIENCY VIRUS INFECTION OF MACROPHAGES
cover slips were stained 22 d after infection. Coverslips were washed twice with PBS, fixed
with methanol for 30 min at room temperature, and incubated with 20% nonimmune rabbit
serum and 5% nonimmune goat serum for 20 min at room temperature. They were then
overlaid for 45 min at room temperature with IgG purified from HIVseropositive human
serum (Af i-gel; Bio-Rad Laboratories, Richmond, CA) at a concentration of 0.35 mg/ml
diluted in PBS containing 5% goat serum and 5% rabbit serum. Coverslips were washed
three times with PBS and incubated for 30 min with fluorescein-conjugated goat F(aV)2
anti-human IgG (Boehringer Mannheim Biochemicals) diluted 1 :60 in PBS with 50% FCS,
10°Jo goat serum, 10% rabbit serum, and 0.5% Evans blue as a counterstain to minimize
autofluorescence.
Results
MDM.
￿
Monocyte/macrophages were prepared from peripheral blood ofnormal
human subjects and were infected as MDM after 7-14 d in culture. On the day of
preparation, >95% of these cells exhibited monocyte markers, as they did at the
time of infection, and very few cells showed T cell markers (Table I and Fig. 1).
These cells expressed very low levels of CD4 by flow cytometry on the day of prepa-
ration (Fig. 1), and CD4 could not be detected by fluorescent microscopy on ad-
herent MDM at the time of infection (Table 1).
HIVI Replication in Monocyte-derivedMacrophages and Lymphocytes.
￿
We selected three
HIV-1 strains as prototypes, HIB, DV, and SF162, and compared their replication
in MDM, PBL, a promonocytic line (U937), and a T cell line (SUP-TI). Virus in-
ocula were standardized by their content of p24 antigen, and cultures were infected
TABLE I
Characteristics of Cell Populations Used for HIV Infection
Values are the percentage of positive cells. Monocytes were characterized im-
mediately after separation from PBMC (day 0), and after culture as adherent
MDM at day 7 and 60. PBMC fraction was characterized immediately after
Ficoll-Hypaque isolation before further separation. PBL cultures were obtained
by culturing PBMC for 4 d, with PHA stimulation and serial depletion of plastic-
adherent cells. U937, promonocytic cell line; SUP-TI, T lymphocyte cell line.
Binding ofmAbs to macrophage markers(OKM 1 and Leu-M3), T lymphocyte
markers (OKT3 and OKTI1), B lymphocyte marker (HD37), and CD4 (OKT4)
was assessed by fluorescence microscopy. Nonspecific esterase (NSE), latex
phagocytosis, and Fc receptors were also assessed by microscopy, as described
in Materials and Methods. Percentage of cells positive is based on a minimum
of 300 cells counted.
Marker
Monocyte/macrophage
0 d 7 d 60 d
PBMC
(0 d)
PBL
(4 d) U937 SUP-Tl
OKM1 99 82 63 20 2 0 0
Leu-M3 95 43 ND 19 0 5 0
OKT3 2 0 ND 52 78 0 1
OKTl1 7 0 0 64 75 0 98
OKT4 4 0 ND 35 31 96 97
HD37 0 1 0 5 15 0 0
NSE 92 97 65 ND ND 95 ND
Latex
phagocytosis 91 98 88 ND ND <5 ND
Fc receptors 96 98 ND ND ND 85 NDW m
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with ti100 ng/106 cells. Infection was followed by examining supernatants for con-
centration of p24 antigen and infectious virus, by p24 assay ofcell lysates for cell-
associated antigen, and by immunohistochemical staining ofviral antigens for the
proportion of cells infected.
The threevirus strains showed sharply different patterns ofreplication in MDM
(Figs. 2 and 3); strain SF162 produced moderatelevels ofp24antigen and infectious
virus, while strain III B produced little or no antigen or infectious virus, and strain
DV showed an intermediate pattern. All three strains ofHIV-1 replicated to ahigh
titer in PBL, with similar kinetics ofantigen and infectious virus production (Figs.
0 SF182
￿
0 Dv
￿
0 111e
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FIGURE 1.
￿
Purity and surfacecharacteristics ofmonocytes
immediately after isolationfrom PBMC. Flow cytometry
profiles represent the entire population of cells isolated.
Monocyteswere stainedwith mAbs formonocyte markers
(OKMI, Leu-M3), class II expression (I2), CD4 expres-
sion (OKT4),Tlymphocyte marker(OKT3),Bcell marker
(HD37), and NK cell marker (1373.1). An IgG2a control
antibody is shown.
FIGURE 2. Antigen production by three
strains of HIV-1 (SF162, DV, and IIIB) in
MDM(A)and PBL(B). MDMcultured for
7dandlymphocytescultured for4dwere in-
fected with equalamountsofvirus(100 ng p24
antigen per 106 cells) for 2 h, washed, and
maintained as described. The culture super-
natantwasperiodically tested forp24antigen.1154 HUMAN IMMUNODEFICIENCY VIRUS INFECTION OF MACROPHAGES
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FIGURE 3.
￿
Replication of three strains of
HIV-1 (SF162, DV, and 11113) in MDM (A)
andPBL(B). MDMcultured for7dandlym-
phocytes cultured for 4 dwere infected with
equal amountsofvirus(100 ng ofp24antigen
per 106cells) for2 h, washed, andmaintained
as described. The culture supernatant was
tested periodically forinfectious virusproduc-
tion by titration on PBL.
2 and 3). Ofnote, even the monocyte-tropic strain SF162 replicated to titers 10- to
100-fold higher in PBL than in MDM.
Since infected MDM consistently produced lower levels of supernatant p24 an-
tigen than did infected PBL, a search was made for sequestration of p24 antigen
in infected MDM. Thoroughly washed cells were lysed and the p24 content ofthe
lysates compared with p24 in the supernatants from the same cultures (Table II).
Of the total p24 antigen, ti3:4 was associated with the supernatant and 1:4 with
the cell, and this ratio was similar for infected MDM and PBL.
TABLE II
Supernatant and Cell-associated Viral Antigen in HIV-1-infected MDM
andLymphocyte (PBL) Cultures
MDM and lymphocyte cultures were infected as described. At each time point, culture was
dividedinto supernatant andcellular component, andp24antigenlevels were determined. Values
are expressed as the total p24 antigen content in each compartment of the culture.
Cell Day
III13
Supernatant Cellular
DV
Supernatant
ng
Cellular
SF162
Supernatant Cellular
MDM 6 0.15 <0.01 10 .1 2.8 13.3 0.8
13 0.06 0.06 29.2 50.0 63.0 18.2
21 0.17 0.09 47 .0 8.9 35.8 9.7
PBL 7 14 2 187 58 228 32
13 29 22 71 39 118 11
22 131 33 58 15 104 10COLLMAN ET AL.
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Donor VariabilityinMDM.
￿
Replicateexperiments withMDMare shown inTable
III. Although strain IIIB usually produced no antigen or only trace levels (0.01-0.1
ng/ml), titers of2-4 ng/ml were occasionally seen; conversely, strain SF162 usually
produced titers of 50-150 ng/ml, but occasionally did not exceed 1 ng/ml. There
appeared to be both experiment-to-experiment and donor-to-donor variation. De-
spite this biological variation, within each experiment there was a consistent gra-
dient of replication, from SF162 (highest) to IIIB (lowest).
ViralAntigen inHIV-1-infectedMDM
￿
To determinethe proportion ofinfectedcells
and the morphological effects ofinfection, MDM, inoculated 22 d previously with
SF162, were examined forviralantigenby immunofluorescence (Fig. 4). Many cells
contained viral antigen, and these cells were readily identified as macrophages be-
causeoftheirlargesize, abundant cytoplasm, and multiple nuclei. Antigen was seen
in the cytoplasm and not in nuclei and was usually concentrated in multiple focal
accumulations. A striking feature of infected cells was the localization of antigen
at sites of cell-to-cell contact (Fig. 4 B).
Viral antigen was clearly associated with multinucleated MDM. Cultures were
mononuclear at the time of preparation, but during cultivation (in the absence of
infection) the cells gradually fused to form small syncytia. However, infected com-
panion cultures demonstrated much more pronounced syncytia formation (Fig. 5),
and the largest syncytia were almost always antigen positive (Fig. 4 C). These mul-
tinucleated giant cells expanded over time and formed cellular "lakes" with >100
nuclei, yet remained viable andcontinued to produce virus for >8 wk. The associa-
tion ofsyncytia formation with infection is demonstrated in Table IV, which com-
pares the number ofnuclei in antigen-positive and antigen-negative MDMwithin
a single infected culture. Antigen-positive MDMform much larger syncytia, while
antigen-negative MDM form smaller syncytia very similar to the size ofthose seen
in uninfected cultures. Table IV also shows that in infected cultures, N2:3 ofnuclei
(representing 2:3 of the initial monocytes in the original culture) were in antigen-
positive cells.
TABLE III
Variability of HIV-1 Replication in MDM
MDM were prepared and infected as described in Materials and Methods. All
cultures were followed for at least 30 d after infection and peak titers ofp24 anti-
gen in supernate are recorded in this table. Titer of p24 antigen: + + + +
(100-1,000 ng/ml); + + + (10-100 ng/ml); + + (1-10 ng/ml); + (0.1-1 ng/ml);
and t (<O.1 ng/ml).
Exp. Donor IIIB DV SF162
1 A - + +++
2 B - ++ ++++
3 B - + +++
4 C + + ++++
5 C + ++ +++
6 D t ++ +++
7 D t + + +
9 E ++ +++ ++++
10 F ++ +++ ++++
11 G + ++ ++1156 HUMAN IMMUNODEFICIENCY VIRUS INFECTION OF MACROPHAGES
FIGURE 4 .
￿
Viral antigens in infectedMDM. Macrophages cultured for 14dwere infected with
HIV-1 SF162 (75 ng ofp24 antigen per6 x 10 5 cells), and22 d later were fixed, stained for viral
antigens, andexamined by immunofluorescence . (A) Infected culture showinga single small poly-
karyon with focal areas of viral antigen . (B) Infected culture with antigen-positive polykaryon
and antigen at points ofcontact with other cells . (C) Infected culture showing a very large poly-
karyon with multiple foci of viral antigen . (D) Uninfected culture of same age showinga heter-
ogenous population of cells that contain up to several nuclei (x 250) .
Large syncytia were frequently seen in cultures infected with strain SF162, less
commonly with strain DV, and never in MDM infected with strain IIIB . However,
among SF162-infected cultures, there was only a general correlation between the
degree of giant cell formation and the titer of p24 antigen in the supernate .
U937 andSUP-TI Cell Lines.
￿
Both the promonocytic line, U937, and theT cell
line, SUP-TI, supported replication of strains IIIB andDV to high titer, but strain
SF162 replicated poorly with only trace amounts of p24 antigen detected (Fig . 6) .
Similarly, as measured by TCID50, strains IIIB and DV produced high titers of
free infectious virus in both U937 and SUPT1 cells, while no infectious virus wasCOLLMAN ET AL .
FIGURE 5 .
￿
Morphology of infected MDM . Macrophages cultured for 14 d were infected with
HIV-1 SF162 (75 ng ofp24 antigen per 6 x 10 5 cells), and 22 d later cells were fixed and stained
by a modified Wright-Giemsa method. (A) Infected culture showing verylarge syncytia. (B) Unin-
fected culture showing smaller multinucleated cells (x250) .
TABLE IV
The Distribution of Polykaryocytes in HIV-1-infected and
Uninfected Cultures ofMDM
MDM cultured for 14 d were infected with HIV-1 strain SF162 (75 ngp24 anti-
gen per 6 x 10 5 cells), incubated for 22 d, and stained for viral antigen by im-
munofluorescence . Individual cells were classified according to the number of
nuclei and presence of antigen; the total nuclei in the cells in each category is
recorded.
' Totals of each column .
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Nuclei/cell
Uninfected
Nuclei Percent
Without
Nuclei
Infected
antigen With
Percent Nuclei
antigen
Percent
1 98 24 163 33 4 0
2-5 200 48 135 28 64 7
6-10 52 13 85 17 102 11
11-25 66 16 74 15 151 16
26-50 0 0 32 7 218 23
>50 0 0 0 0 415 44
416' 100 489 100 954 1001158 HUMAN IMMUNODEFICIENCY VIRUS INFECTION OF MACROPHAGES
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FIGURE 6. Antigen production by three
strains of HIV-1 (SF162, DV and IIIB) in
U937 cells(A) and SUP-TI cells (B). Cells were
infected with equal amounts of virus (50 ng
ofp24 antigen per 106 cells) for 2 h, washed,
and maintainedas described. Supernatant was
tested periodically for p24 antigen.
produced in these two cell lines after infection with strain SF162 (data not shown).
Infection of U937 cells was noncytopathic, with no morphological changes or cell
death, andviral antigenwasdistributeddiffuselythroughout the cytoplasmofvirtu-
ally 100% ofcellsat peak infection. Infected SUPTI cells were also uniformly posi-
tive for cytoplasmic viral antigen but, in contrast, formed extensive syncytia with
rapid cell killing. After variable periods of time, however, a non-syncytia-forming
chronicallyHIVIIIB-infected population ofSUPTI cellsemerged (datanot shown).
The pattern oftropism of the three strains of HIV-1 in four different cell types
is summarized in TableV. Strains SF162 and IIIB showed reciprocal patterns, since
SF162 replicated in MDM but poorly in U937 or SUPT1 cells, while strain IIIB
replicated in U937 and SUPTI, but poorly or not at all in MDM. PBL were the
TABLE V
Antigen Production by Selected Strains of HIV-1 in Primary
Cultures and Transformed Lines of MDM and Lymphocytes
U937, promonocytic cell line; SUP-T1, T lymphocyte cell line. Titers
ofp24 antigen in supernatant are reported as: + + + + + (>1,000 ng/ml);
+ + + + (100-1,000 ng/ml); + + + (10-100 ng/ml); + + (1-10 ng/ml);
+ (0.1-1 ng/ml); t (<O.1 ng/ml). Values are the peak titers and represent
the medians of 3-11 experiments.
Cell type Strain IIIB Strain DV Strain SF162
MDM + ++ +++
PBL ++++ ++++ ++++
U937 +++++ +++++ t
SUP-T1 +++++ +++++ tCOLLMAN ET AL.
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only one of the four cell cultures in which all strains replicated to high titer. It is
noteworthy that the promonocyte line, U937, showed a totally different pattern of
permissiveness than did MDM, and that the T cell line, SUP-TI, showed a totally
different pattern of permissiveness than did PBL.
Discussion
HIV strains are heterogeneous in their host range and infect a wide variety of
cell types (38-41). Therefore, celltropismisbest definedifviruses andcellsare studied
in multiple combinations and cell lines are compared with the corresponding pri-
marycells. By systematically examiningthe replication ofa selected panel ofproto-
type HIV-1 strains in primary monocyte-derived macrophages, primary lympho-
cytes, apromonocytic cell line, and alymphoid cellline, we have developed a matrix
that represents a spectrum of HIV-cell interactions from permissive to highly re-
stricted (Table V). Our results confirm previous work, demonstrating that HIV-1
strains display differing degrees ofmonocyte tropism, but challenge the widespread
use ofcelllines as surrogatesfor primary macrophagesand T lymphocytes in studies
of tropism.
We foundthat thethreeisolatesstudied exhibitagradationin theirabilityto replicate
in macrophages; macrophages are most permissive for SF162, intermediate in per-
missiveness for DV, and least permissive for IIIB. These results confirm previous
findings (6, 16, 21-25) ofmonocyte tropismin HIV isolates anddocument that some
HIV strains may undergo aproductive infection in the same macrophages that will
only support persistent latent infection of other HIV strains.
The promonocytic U937 cell line iswidely used as a surrogatefor monocyte/mac-
rophages in studies of HIV infection (42-46). U937 cells resemble promonocytes
rather than MDM (47), and there are other significant differences between U937
cells andmonocyte/macrophages, includingCD4 expression, which ishigh in U937
cellsbutvery low in MDM. U937 cells arereadily infectedby thelymphocyte-tropic
strain IIIB and do not support replicationofthe monocyte-tropic strain SF162, which
is the inverse ofthe pattern seen with primary MDM. SUP-TI is one of a number
of cell lines used as a model for T4 lymphocytes (48) and expresses high levels of
CD4. However, SUP-TI cells fail to support replication ofstrain SF162, which repli-
catesto hightiterin primary lymphocytes(24). Thus, the promonocytoid U937 and
lymphoid SUPTl cell lines demonstrate similar patterns of viral restriction (Table
V), and are not adequate surrogates for primary MDMand PBL in studies ofviral
host cell tropism. It is possible that U937 cells induced to "differentiate" to a more
mature phenotype would demonstrate a pattern ofpermissiveness more representa-
tive of macrophages (49-51).
Because T4lymphocytesare exquisitely permissive forHIVinfection, it is critical
to document that HIV infection ofMDMinvolves macrophages and is not limited
to acontaminating fraction oflymphocytes. Our immunofluorescence observations
indicate that a large proportion of cells are antigen positive and that infection is
strongly associated with syncytium formation, the best establishedcytopathic effect
ofHIV. Since >90% ofthe cells in these cultures exhibitmacrophage markers (Table
I), it seems clear that MDM are heavily infected. HIV antigens are concentrated
infocal accumulations (Fig. 4), and this could reflectboth internal buddingofvirus
(16) andphagocytic accumulation ofvirionsandviralproteins. Theimmunofluorescent1160 HUMAN IMMUNODEFICIENCY VIRUS INFECTION OF MACROPHAGES
images also suggest (Fig. 4 B) that HIV may spread by cell-to-cell transmission of
virus as well as by production of free infectious virions, which could be relevant
to the potential blocking effects of soluble T4 or of antiviral antibody.
Summary
To characterize the host range of different strains of HIV1, we have used four
types of cells, primary monocyte-derived macrophages (MDM), primary PBL, a
promonocyte cell line (U937), and a CD4+ T cell line (SUP-TI) . These cells were
infected with three prototype strains of HIV-1, a putative lymphocyte-tropic strain
(IIIB), and two putative monocyte-tropic strains (SF162 and DV). Infections were
monitored by assays for infectious virus, for cell-free and cell-associated viral an-
tigen (p24), and for the proportion ofcellsinfected by immunohistochemical staining.
It was concluded that: (a) the use offour different cell types provides a useful bio-
logical matrix for distinguishing the tropism of different strains of HIV1; this ma-
trix yields more information than the infection ofany single cell type. (b) A monocyte-
tropic strain of HIV1, such as strain SF162, shows a reciprocal host range when
compared with a lymphocyte-tropic strain such as IIIB; strain SF162 replicates well
in primary MDM but not in U937 or SUP-TI cells, while strain IIIB replicates well
in both U937 and SUP-T1 cells but not in MDM. (c) Both lymphocyte-tropic and
monocyte-tropic strains of HIV-1 replicate well in PBL. (d) The promonocyte cell
line, U937, and the T cell line, SUP-TI, differ markedly from primary cells, such
as MDM and PBL, in their ability to support the replication of different strains
of HIV1; thesecell lines cannot be used as surrogates for primary cells in host range
studies of HIV-1 strains.
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and consultation.
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